Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 511523 | NSE Symbol : NIYATILEAS | ISIN : INE882C01035 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
21-May-2025	30-May-2025	Final Dividend	Final Dividend & Audited Results The Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2025. (As Per BSE Announcement Dated on :30.05.2025)
04-Feb-2025	12-Feb-2025	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve unaudited financial results of the Company for the quarter and nine months ended 31st December 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about outcome of the Meeting of Board of Directors of the Company held today i.e. February 12, 2025 as under: 1. The Board has approved and taken on record the unaudited financial results for the quarter and nine months ended December 31, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 4.40 p.m. Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, we enclose the following: 1. Statement showing unaudited financial results for the quarter and nine months ended December 31, 2024. 2. Limited Review Report on unaudited financial results for the quarter and nine months ended December 31, 2024. (As Per BSE Announcement Dated on 12/02/2025)
06-Nov-2024	14-Nov-2024	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited financial results of the Company for the quarter and half year ended 30th September 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. November 14, 2024 as under: 1. The Board has approved and taken on record the unaudited financial results for the quarter and half year ended September 30, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m. (As per BSE Announcement Dated on 14/11/2024)
06-Aug-2024	14-Aug-2024	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. Unaudited financial results of the Company for the quarter ended 30th June 2024. 2. To increase Authorized Share Capital of the Company. 3. Re-appointment of Mr. Bhavin Shah as Managing Director of the Company subject to approval of shareholders of the Company. 4. Re-appointment of Mrs. Shruti Shah as Executive Director of the Company subject to approval of shareholders of the Company. Please find enclosed Outcome of Board Meeting held on 14th August, 2024. (As Per Bse Announcement Dated on 14.08.2024) 5. Draft Directors Report for the financial year ending 31st March 2024. 6. Draft notice convening 32nd Annual General Meeting of the Company. 7. To fix Book Closure date. 8. To appoint a Director in place of Mrs. Shruti Shah who retires by rotation. Please find enclosed Intimation under Regulation 30 of SEBI (LODR) for Reappointment of Managing Director and Executive Director of the Company. (As per BSE Announcement Dated on 14/08/2024)
21-May-2024	30-May-2024	Final Dividend	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve The Audited Financial Results for the quarter and financial year ended 31st March 2024 and recommendation of dividend if any. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 30, 2024 as under: 1. The Board has approved and taken on record Audited Financial Results for the quarter and year ended March 31, 2024. 2. To conserve resources of the Company, the Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m Please find attached herewith the details under Regulation 30 of SEBI LODR for appointment of Internal and Secretarial Auditor. (As Per BSE Announcement dated on 30.05.2024)
15-Feb-2024	20-Feb-2024	Raising funds through Debt Instr.	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/02/2024 inter alia to consider and approve Examine evaluate various options to raise funds by issue of Preference / Right shares along with Banking Loan for expansion. This is to inform you that the Board of Directors of the Company at its meeting held today, i.e. 20th February, 2024, inter alia, has approved the following: 1. The Board has approved expansion project and estimated project cost for expansion will be Rs. 33 Crores, including purchase of Land, Construction of Building, Plant & Machinery and other Infrastructure. 2. Out of Rs. 33 Crores, Rs. 8 Crores to be raised from bank by way of borrowings. 3. Board has decided to issue new 99,99,238 equity shares having face value of Rs. 10/- each at a premium of Rs. 15/- per share by way of Rights Issue to the existing shareholders of the Company at an issue price of Rs. 25/- per equity share in the ratio of 1:2 i.e. 1 (one) new Right Share for every 2 (two) existing Equity Shares held by the eligible shareholders. The Board Meeting commenced at 3.00 p.m. and concluded at 4.00 p.m. (As per BSE Announcement Dated on 20/02/2024) In continuance of announcement of Outcome of Board Meeting dated 20th February, 2024, please find attached herewith the additional details pursuant to SEBI Circular dated July 13, 2023 and Regulation 30 of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 21.02.2024)
02-Feb-2024	10-Feb-2024	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial results of the Company for the quarter and nine months ended 31st December 2023. 2. Company is planning to do expansion and to meet up those Capital Expenditure to consider capital raising options for the Company as the Board may deem appropriate. This is to inform you that the Board of Directors of the Company at its meeting held today, i. e. 10th February, 2024, inter alia, has approved the following: 1. The Board has approved and taken on record the unaudited financial results for the quarter and nine months ended December 31, 2023. 2. For meeting exports and local demand, Board has decided to increase manufacturing capacity, and to meet such capex, Board has decided to raise funds by way of preferential offer, rights issue or such other methods or combinations as may be considered appropriate. The Board Meeting commenced at 3.00 p.m. and concluded at 4.00 p.m. (As per BSE Announcement Dated on 10/02/2024)
30-Oct-2023	08-Nov-2023	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Unaudited financial results of the Company for the quarter and half year ended 30th September 2023. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. November 08, 2023 as under: 1. The Board has approved and taken on record the unaudited financial results for the quarter and half year ended September 30, 2023. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m. Please find attached herewith the Financial Results for the quarter and half year ended 30th September, 2023. (As Per BSE Announcement Dated on 08/11/2023)
14-Sep-2023	25-Sep-2023	Bonus Issue	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2023 inter alia to consider and approve Allotment of 9999238 Equity Shares of Rs. 10/- each by way of Bonus Issue to such members whose name appears in Register of Members as on September 22 2023 being the record date fixed for the said purpose in the proportion of 1 (One) new fully paid up equity share of Rs. 10/- each for every 1 (One) existing fully paid up Equity Share of Rs. 10 each held by them i.e. in the ratio of 1:1. Company have received in-principle approval from BSE vide Letter No. LOD/Bonus/TP/DA/615/2023-24 dated September 12 2023 for issue and allotment of 9999238 Bonus Equity Shares of Rs. 10/- each in the ratio of 1:1. Pursuant to provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, we would like to inform you that the meeting of the Board of Directors of the company at its Meeting held today i.e. September 25, 2023 has inter-alia approved the following business: Allotment of 99,99,238 Bonus Shares in the ratio of 1:1 i.e. 1 (One) Equity Share of Rs. 10/- each for every 1 (One) existing Equity Share of Rs. 10/- each to the equity shareholders entitled thereto as on September 22, 2023 being the Record Date fixed for the purpose. The Board Meeting commenced at 2.00 p.m. and concluded at 3.30 p.m. (As per BSE Announcement Dated on 25/09/2023)
04-Aug-2023	14-Aug-2023	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. To consider and approve unaudited financial results of the Company for the quarter ended 30th June 2023. 2. To increase Authorized Share Capital of the Company. 3. To issue Bonus Shares to the equity shareholders of the Company. 4. To approve draft Directors Report for the financial year ending 31st March 2023. 5. To approve the draft notice convening 31st Annual General Meeting of the Company. 6. To fix Book Closure date. 7. To appoint a Director in place of Mr. Yogesh Shah who retires by rotation. 8. Any other business with permission of the Chair. Further to our intimation to the Stock Exchange vide our letter dated June 30 2023 for closure of trading window we would like to inform you that the trading window for dealing in the securities of the Company which was closed from July 01 2023 will be opened on August 17 2023 as per the provisions of SEBI (Prohibition of Insider Trading Regulations) 2015. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. August 14, 2023 as under: 1. The Board has approved and taken on record the unaudited Financial Results for the quarter ended June 30, 2023. 2. The Board has considered and approved to increase Authorized Share Capital from Rs. 20 crore to Rs. 31 crore and consequent Alteration in Memorandum of Association. 3. The Board has considered and approved issue of Bonus equity shares in the ratio of 1:1 i.e. 1 fully paid up equity share for every 1 fully paid up equity shares held and accordingly fix record date for the purpose of Bonus Issue. 4. The Board has approved Director's Report for the financial year ending 31st March, 2023. Intimation for appointment of Directors of the Company. (As Per BSE Announcement Dated on 14.08.2023) This is with reference to our announcement dated 14th August, 2023 filed under Regulation 30 of SEBI (LODR) Regulations, 2015. In this regard, we are hereby submitting additional details as per SEBI Circular dated September 09, 2015, for Outcome of Board Meeting filed under Regulation 30 of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 17.08.2023)
13-May-2023	22-May-2023	Accounts	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 inter alia to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March 2023 and recommendation of dividend if any. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 22, 2023 as under: 1. The Board has approved and taken on record the Audited Financial Results for the quarter and year ended March 31, 2023. 2. The Board has not recommended final dividend on equity shares of the Company for the financial year 2022-23. The Board Meeting commenced at 5.00 p.m. and concluded at 5.40 p.m. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Statement showing the Audited Financial Results for the quarter and year ended March 31, 2023. 2. Auditors Report on the Audited Financial Results for the quarter and year ended March 31, 2023. 3. Declaration in respect of Audit Report with Unmodified Opinion. (As Per BSE Announcement Dated on 22.05.2023)
06-Mar-2023	10-Mar-2023	Preferential Issue	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2023 inter alia to consider and approve Allotment of Equity Shares on preferential basis to Non Promoters of the Company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. March 10, 2023 as under: 1. Allotment of 30,65,000 Equity Shares having face value of Rs. 10/- each at a premium of Rs. 9.25/- per Equity Share to Non-Promoters, further in pursuance of resolution for preferential issue passed by the members at the Extra-Ordinary General Meeting held on 10th January, 2023. The Company has received in principle approval from BSE Limited vide its letter no. LOD/PREF/VJ/FIP/3193/2022-23 dated 6th March, 2023. The Board Meeting commenced at 11.00 a.m. and concluded at 11.45 a.m. (As Per BSE Announcement dated on 10.03.2023)
04-Feb-2023	13-Feb-2023	Quarterly Results	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve unaudited financial results of the Company for the quarter and nine months ended 31st December 2022 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. February 13, 2023 as under: 1. The Board has approved and taken on record unaudited financial results of the Company for the quarter and nine months ended December 31, 2022. The Board Meeting commenced at 5.00 p.m. and concluded at 5.40 p.m. (As Per BSE Announcement dated on 13.02.2023)
28-Nov-2022	05-Dec-2022	EGM	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/12/2022 inter alia to consider and approve Intimation of Board Meeting as per Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Outcome of Board Meeting held on 05th December, 2022 (As per BSE Announcement Dated on 05/12/2022)
14-Nov-2022	23-Nov-2022	Preferential Issue	Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/11/2022 inter alia to consider and approve Allotment of Equity Shares on Preferential basis to promoters and other than promoters group. Outcome of Board Meeting held on 23rd November, 2022 (As per BSE Announcement Dated on 23/11/2022)

1 2

LOGIN HERE

Veerhealth Care Ltd

Board Meeting